Merck expects to sell $5 billion to $6 billion of its new Covid treatment pill in 2022
February 03, 2022 at 08:34 AM EST
CEO Rob Davis said Merck is on track to fulfill its commitment in the coming days of delivering 3.1 million courses of its Covid treatment pill to the U.S.
